PFKFB3 and cancer: Firstly, inhibition of glycolysis upstream of PFKFB3 by 2-DG did not result in a cancer-specific synthetic lethality with carboplatin (Figure 1E), in line with the previously reported non-glycolytic role of PFKFB3 in promoting cell proliferation from its nuclear localization [20].